Pharma

Kazakhstan to undergo PIC/S on-site assessment in 2027

Regulatory Affairs top-pharma -
Kazakhstan has been approved for an on-site assessment mission and an observed inspection in 2027 as part of its application for membership of the...

FDA proposes framework for individualized gene therapies as CMS expands access

Biotech top-pharma -
The US Food and Drug Administration (FDA) has proposed a regulatory framework for individualized human genome editing therapies, while the Centers for Medicare &...
spot_imgspot_img
Load more